Canada markets open in 1 hour 50 minutes
  • S&P/TSX

    21,537.45
    +179.89 (+0.84%)
     
  • S&P 500

    4,662.85
    +3.82 (+0.08%)
     
  • DOW

    35,911.81
    -201.79 (-0.56%)
     
  • CAD/USD

    0.7997
    +0.0007 (+0.08%)
     
  • CRUDE OIL

    84.97
    +1.15 (+1.37%)
     
  • BTC-CAD

    52,257.00
    -1,478.37 (-2.75%)
     
  • CMC Crypto 200

    999.77
    -25.96 (-2.53%)
     
  • GOLD FUTURES

    1,814.10
    -2.40 (-0.13%)
     
  • RUSSELL 2000

    2,162.46
    +3.02 (+0.14%)
     
  • 10-Yr Bond

    1.7720
    0.0000 (0.00%)
     
  • NASDAQ futures

    15,351.25
    -244.50 (-1.57%)
     
  • VOLATILITY

    21.53
    +1.22 (+6.01%)
     
  • FTSE

    7,568.89
    -42.34 (-0.56%)
     
  • NIKKEI 225

    28,257.25
    -76.27 (-0.27%)
     
  • CAD/EUR

    0.7021
    +0.0020 (+0.29%)
     

FDA panel narrowly backs COVID-19 pill from Merck

A panel of U.S. health advisers narrowly backed a closely watched COVID-19 pill from Merck. The FDA panel voted 13-10 that the antiviral drug’s benefits outweigh its risks, including potential birth defects if used during pregnancy. (Dec. 1)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting